Orion Corporation

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40012028

Informations générales

Localisation

Finland

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

26/09/2024

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Description complète des objectifs

Orion Corporation commits to reduce absolute scope 1 and 2 GHG emissions 70% by 2030 from a 2023 base year. Orion Corporation also commits that 78% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution will have science-based targets by 2029.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

FI0009014369

LEI

74370029VAHCXDR7B745

Source : Science Based Targets initiative | Données publiques